| One-month Latent Tuberculosis Treatment for Renal Transplant Candidates (NCT05411744) | Rutgers, The State University of New Jersey | 2022-07-01 |
| Brief Educational Video for Patients Prescribed LTBI Treatment (NCT05412212) | Kaiser Permanente | 2022-06-03 |
| Economic Incentives and vDOT for Latent Tuberculosis Infection (NCT05022862) | Johns Hopkins University | 2022-02-07 |
| New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis (NCT05621343) | Region Skane | 2021-12-21 |
| Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis (NCT05073926) | Region Skane | 2021-09-30 |
| Implementation of an Integrated Care Strategy for Children Contacts of Patients With Tuberculosis (NCT04331262) | Corporacion para Investigaciones Biologicas | 2021-07-26 |
| Comorbidities and Coinfections in Latent TB (NCT04642755) | Tuberculosis Research Centre, India | 2021-04-19 |
| Impact of LTBI Treatment on Glucose Tolerance and Chronic Inflammation (NCT04830462) | Herlev and Gentofte Hospital | 2021-04-15 |
| Microneedles for Diagnosis of LTBI (NCT04552015) | The HIV Netherlands Australia Thailand Research Collaboration | 2021-04-08 |
| TB Screening Improves Preventive Therapy Uptake (NCT04557176) | University of California, San Francisco | 2020-11-16 |
| BCG Re-vaccination for Primary Tuberculosis Prophylaxis in the Prison Population (NCT05541952) | Federal University of Mato Grosso | 2020-08-17 |
| Options for Delivering Isoniazid-Rifapentine (3HP) for TB Prevention (3HP Options Implementation Trial) (NCT03934931) | University of California, San Francisco | 2020-07-13 |
| Prevalence of Latent Tuberculosis in High Risk Children (NCT03910946) | Assiut University | 2020-07-01 |
| GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact Assessment (NCT04528823) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2020-01-31 |
| Tuberculosis Clinical Trials Consortium Study 35 (NCT03730181) | Centers for Disease Control and Prevention | 2019-11-12 |
| Improving Rhode Island's Tuberculosis Preventive Services in Primary Care (NCT04188041) | Kent Hospital, Rhode Island | 2019-10-02 |
| 2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB. (NCT03988933) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2019-09-20 |
| Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI (NCT03474029) | Centers for Disease Control and Prevention | 2019-08-01 |
| Screening for Tuberculosis in Pregnancy (NCT04098341) | Queen Mary University of London | 2019-07-01 |
| Video Based Directly Observed Therapy for Latent TB (NCT03783728) | St. Louis University | 2019-06-30 |
| Doravirine, Rifapentine and Isoniazid Interaction (NCT03886701) | Walter K. Kraft | 2019-04-22 |
| Multi-site Cohort Study for the Development of Personalized Pharmacotherapy in Patients With Tuberculosis (TB) (NCT05280886) | Inje University | 2018-07-24 |
| Early Diagnosis of Active Tuberculosis Using Ultra Low-dose Chest CT (NCT03220464) | Seoul National University Hospital | 2017-06-20 |
| COMPArison of Screening Strategies for Active TuBerculosis (COMPASS-TB) (NCT06408129) | University Hospital, Montpellier | 2017-01-31 |
| Completion and Acceptability of Treatment Across Primary Care and the commUnity for Latent Tuberculosis (NCT03069807) | Queen Mary University of London | 2017-01-01 |
| Latent Tuberculosis Infection in Korean Health Care Workers (NCT03010111) | Hanyang University | 2016-12-01 |
| Improving the Detection of Active Tuberculosis in Accident and Emergency Departments (NCT02512484) | Public Health England | 2016-05-01 |
| Promoting Adherence to Treatment for Latent TB Infection Through Text Messaging (NCT02690818) | University of Arizona | 2016-04-01 |
| Vitamin D Supplementation in TB Prevention (NCT02276755) | Harvard School of Public Health (HSPH) | 2015-09-01 |
| Ultralow Dose Computed Tomography in High-risk Drug-resistant Tuberculosis Contacts (NCT02454738) | Seoul National University Hospital | 2015-06-01 |
| Development of Human Nasal Challenge Models With Microbial Constituents and Grass Pollen (NCT02090374) | Imperial College London | 2014-03-01 |
| Latent Tuberculosis in Second Generation Immigrants From High Risk Countries Compare to Low-risk Young Israeli Adults (NCT02073669) | Sheba Medical Center | 2014-03-01 |
| A Phase I/IIa AERAS-456 in HIV-Negative Adults With & Without Latent Tuberculosis Infection (C-035-456) (NCT01865487) | Aeras | 2013-08-01 |
| Testing for Tuberculosis in the United Kingdom HIV Infected Population (NCT02712671) | University College, London | 2013-06-01 |
| Effect of Filarial Infection on Immune Responses in Latent Tuberculosis (NCT01547884) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-01-01 |
| Evaluation of Diabetes Control and Effect on Transmission and Development of Tuberculosis (NCT03498534) | Instituto Nacional de Salud Publica, Mexico | 2012-09-01 |
| Determining Risk in Latent Tuberculosis (NCT01571739) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-01-02 |
| Safety and Immunogenicity Study of AERAS-456 Vaccine for Tuberculosis (NCT01967134) | Aeras | 2011-11-01 |
| Training Protocol on the Natural History of Tuberculosis (NCT01212003) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-06-30 |
| Improving Latent Tuberculosis (TB) Diagnosis in Thai Children (NCT00947609) | SEARCH Research Foundation | 2009-08-01 |
| Immune Response to Mycobacterium Tuberculosis Infection (NCT00257907) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-11-18 |
| The Epidemiology of TST Change in Korea (NCT01850043) | Asan Medical Center | 2005-05-01 |
| Use TST and QFT-RD1 Test to Monitor the Tuberculous Infection in Patients, Close Contact People and Health Care Workers (NCT00311220) | Taichung Veterans General Hospital | 2004-01-01 |